康希諾生物-B(06185.HK):提名桂水發及劉建忠為獨立非執行董事候選人
格隆匯11月14日丨康希諾生物-B(06185.HK)發佈公告,Luis BARRETO由於其他工作需要已辭任公司獨立非執行董事、董事會轄下薪酬與考核委員會成員及董事會轄下提名委員會成員,自公司股東特別大會結束後生效;Pierre Armand MORGON由於其他工作需要已辭任公司獨立非執行董事、薪酬與考核委員會主席及提名委員會成員,自公司將於股東特別大會結束後生效;及朱際翔由於其他工作需要已辭任公司監事會主席,自股東特別大會結束後生效。
此外,公司控股股東Xuefeng YU提名桂水發及劉建忠為第一屆董事會獨立非執行董事候選人,以及提名李江峯為第一屆監事會監事候選人。董事會同意上述建議。建議將提呈股東特別大會以供考慮及批准。委任桂先生及劉先生為獨立非執行董事以及委任李女士為監事將於公司股東於股東特別大會批准後生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.